GARDP's Carmen Au presented at the @IUSTI_Europe Congress, highlighting that the development of a potential new #gonorrhoea treatment was made possible through public-private partnerships.
"Fostering this model is key to an ecosystem shift - integrating R&D and #access to prioritize #PublicHealth."
We're very happy to announce that zoliflodacin met its primary endpoint in an unprecedented global pivotal phase 3 clinical trial 🤩
These positive findings offer hope for patients with #gonorrhoea.
W/ @innovivastx 👇
https://t.co/zPpzLS1x8w
#AMR